Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Gastrointestinal 1

Conditions

Precancerous Conditions 1Colorectal Neoplasms 1Colonic Neoplasms 1Adenomatous Polyps 1

Interventions

Fluorouracil 20Leucovorin 18Oxaliplatin 11Irinotecan 10Capecitabine 6Bevacizumab 5Cetuximab 4Levamisole 3Celecoxib 3cediranib 2Watchful Waiting 2Tegafur 2Surveys and Questionnaires 2Psychiatric Rehabilitation 2Folfox protocol 2Counseling 2Cisplatin 2tumor necrosis factor-alpha, CNGRC fusion protein, human 1tipifarnib 1regorafenib 1pertuzumab 1olaparib 1mercaptoundecahydrododecaborate 1gevokizumab 1eniluracil 1cemiplimab 1brivanib 1alpha-Tocopherol 1Vitamin E 1Uracil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Colonic Neoplasms × Rosuvastatin Calcium × Clear all
NCT01011478 2023-08-16

Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery

NSABP Foundation Inc

Phase 3 Terminated
406 enrolled 14 charts
GastrointestinalOther neoplasm

Colonic Neoplasms, Precancerous Conditions, Colorectal Neoplasms, Adenomatous Polyps

Data powered by HemOnc (CC BY 4.0) Colophon âš¡